Literature DB >> 993345

Pathogenesis and characterization of hyperglucagonemia in the uremic rat.

D S Emmanouel, J B Jaspan, S F Kuku, A H Rubenstein, A I Katz, A H Huen.   

Abstract

The pathogenesis of hyperglucagonemia and of the alterations in the pattern of circulating immunoreactive glucagon (IRG) associated with renal insufficiency was studied in rats in which a comparable degree of uremia was induced by three different methods, i.e., bilateral nephrectomy, bilateral ureteral ligation, and urine autoinfusion. Nephrectomized and ureteral-ligated rats were markedly hyperglucagonemic (575 +/- 95 pg/ml and 492 +/- 54 pg/ml, respectively), while IRG levels of urine autoinfused animals (208 +/- 35 pg/ml) were similar to those of control rats (180 +/- 26 pg/ml), indicating that uremia per se does not account for the hyperglucagonemia observed in renal failure. Similarly, plasma IRG composition in this group of animals was indistinguishable from that of controls, in which 88.2 +/- 5.9% of total IRG consisted of the 3,500-mol wt fraction. The same component was almost entirely responsible (82.6 +/- 4.1%) for the hyperglucagonemia observed in ligated rats, while it accounted for only 57.6 +/- 5.0% of the circulating IRG in nephrectomized animals. In the latter group, 36.8 +/- 6.6% of total IRG had a mol wt of approximately 9,000, consistent with a glucagon precursor. This peak was present in samples obtained as early as 2 h after renal ablation and its concentration continued to increase with time reaching maximal levels at 24 h. These results confirm that the kidney is a major site of glucagon metabolism and provide evidence that the renal handling of the various circulating IRG components may involve different mechanisms. Thus, the metabolism of the 3,500-mol wt fraction is dependent upon glomerular filtration, while the uptake of the 9,000-mol wt material can proceed in its absence, as long as renal tissue remains adequately perfused. This finding suggests that the 9,000-mol wt component may be handled by peritubular uptake.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 993345      PMCID: PMC333296          DOI: 10.1172/JCI108581

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Isolation and partial characterization of anglefish proglucagon.

Authors:  A C Trakatellis; K Tada; K Yamaji; P Gardiki-Kouidou
Journal:  Biochemistry       Date:  1975-04-08       Impact factor: 3.162

2.  Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogs.

Authors:  I Valverde; R Dobbs; R H Unger
Journal:  Metabolism       Date:  1975-09       Impact factor: 8.694

3.  Measurement of renal blood flow in the rat.

Authors:  C H Hsu; T W Kurtz; H G Preuss; J M Weller
Journal:  Proc Soc Exp Biol Med       Date:  1975-06

4.  Effect of acute kidney exclusion by ligation of renal arteries on peripheral plasma glucagon levels and pancreatic glucagon production in the anesthetized dog.

Authors:  P J Lefebvre; A S Luyckx
Journal:  Metabolism       Date:  1975-10       Impact factor: 8.694

5.  Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease.

Authors:  K A Hruska; R Kopelman; W E Rutherford; S Klahr; E Slatopolsky; A Greenwalt; T Bascom; J Markham
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

Review 6.  Renal handling of low molecular weight proteins.

Authors:  T Maack
Journal:  Am J Med       Date:  1975-01       Impact factor: 4.965

7.  Hyperglucagonemia in uremia: reversal by renal transplantation.

Authors:  G L Bilbrey; G R Faloona; M G White; C Atkins; A R Hull; J P Knochel
Journal:  Ann Intern Med       Date:  1975-04       Impact factor: 25.391

8.  Evidence of sequential metabolic cleavage of proglucagon to glucagon in glucagon biosynthesis.

Authors:  B D Noe; G E Bauer
Journal:  Endocrinology       Date:  1975-10       Impact factor: 4.736

9.  Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes.

Authors:  S F Kuku; A Zeidler; D S Emmanouel; A I Katz; A H Rubenstein
Journal:  J Clin Endocrinol Metab       Date:  1976-01       Impact factor: 5.958

10.  Cholecystokinin metabolism in man and dogs.

Authors:  J C Thompson; H R Fender; N I Ramus; H V Villar; P L Rayford
Journal:  Ann Surg       Date:  1975-10       Impact factor: 12.969

View more
  9 in total

1.  The renal handling of parathyroid hormone. Role of peritubular uptake and glomerular filtration.

Authors:  K J Martin; K A Hruska; J Lewis; C Anderson; E Slatopolsky
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

2.  The role of the liver in glucagon metabolism.

Authors:  J B Jaspan; A H Huen; C G Morley; A R Moossa; A H Rubenstein
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

3.  Glucagon and insulin binding to liver membranes in a partially nephrectomized uremic rat model.

Authors:  V Soman; P Felig
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

4.  Carbohydrate metabolism and uraemia-mechanisms for glycogenolysis and gluconeogenesis.

Authors:  W H Hörl; J Stepinski; A Heidland
Journal:  Klin Wochenschr       Date:  1980-10-01

5.  Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.

Authors:  R R Dighe; F J Rojas; L Birnbaumer; A J Garber
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

6.  Glucagon metabolism in the rat.

Authors:  D S Emmanouel; J B Jaspan; A H Rubenstein; A H Huen; E Fink; A I Katz
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

7.  Glicentin 1-61 probably represents a major fraction of glucagon-related peptides in plasma of anaesthetized uraemic pigs.

Authors:  F G Baldissera; J J Holst
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

Review 8.  Role of the kidney in hormone metabolism and its implications in clinical medicine.

Authors:  D S Emmanouel; M D Lindheimer; A I Katz
Journal:  Klin Wochenschr       Date:  1980-10-01

9.  Glucose intolerance in uremia (A- and B-cell function during conservative and dialytic management.

Authors:  M M Benedetti; F Santeusanio; G Angeletti; P Filipponi; U Buoncristiani; P Brunetti
Journal:  Acta Diabetol Lat       Date:  1977 Sep-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.